A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Evonik Industries AG operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. It operates through the Advanced Technologies, Custom Solutions, and Infrastructure segments. The Advanced Technologies segment provides polymers for medical applications; crosslinkers; hydrogen peroxide, a sterilizing agent for cleaning silicon wafers and a bleaching agent for the paper and textile industries; fumed and precipitated silicas and silanes for the automotive, tire, electronics, and cosmetics industries; and D-/L-methionine and lysine for animal nutrition. Its Custom Solutions segment provides additives for coatings, adhesives, sealants, polyurethane foams, and lubricants for the cosmetic, cleaning, and pharmaceutical industries. The Infrastructure segment engages in the infrastructure activities and offers butadiene, MTBE, butene-1, isononanol, and DINP for use in the plastic and packaging industries, production of rubber and fuels, and as plasticizers in the construction and automotive sectors. The company was founded in 1847 and is headquartered in Essen, Germany.
Financial Summary
| Share Statistics | EVKIY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $9,401.5 | $3,722.6 | 77% |
|
| Shares Out (Mil) | 533.8 | 87.3 | 89% |
|
| Institutional Ownership | 50.0% | 87.5% | 30% |
|
| Float (Mil) | 251.6 | 117.5 | 77% |
|
| Beta | 0.54 | 0.80 | 30% |
|
| Avg Daily Volume (000s) | 9 | 176 | 16% |
|
| Price Change (52-week) |
(7.3%) | 81.7% | 39% |
|
| Growth | EVKIY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 2.1% | 4.2% | 23% |
|
| Net Income (5yr) | (11.4%) | 1.4% | 28% |
|
| EPS (5yr) | (11.4%) | 3.2% | 20 |
|
| Dividends (5yr) | (3.6%) | 0.0% | 81% |
|
| Cash Flow (5yr) | 15.5% | (15.3%) | 74% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | EVKIY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $15,818 | $3,981 | 89% |
|
| Net Income (TTM) (Mil) | $181 | $70 | 67% |
|
| EPS (TTM) | $0.389 | $0.400 | 51% |
|
| Operating Cash Flow (TTM) (Mil) | $1,689 | $388 | 86% |
|
| Net Cash Flow (TTM) (Mil) | ($174) | $9 | 11% |
|
| Long-Term Debt (Q1) (Mil) | $3,788 | $1,682 | 82% |
|
| Enterprise Value (Q1) (Mil) | $13,119 | $5,497 | 78% |
|
| Valuation | EVKIY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 1.48 | na |
|
| P/E | na | 24.8 | na |
|
| Dividend Yield | na | 1.3% | na |
|
| PEG (5yr hist) | na | 2.0 | na |
|
| Ratios | EVKIY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 24.2% | 29.8% | 27% |
|
| Net Margin | 1.1% | 2.8% | 35% |
|
| ROA | 0.8% | 2.1% | 44% |
|
| ROE | 1.9% | 4.8% | 38% |
|
| Liabilities to Assets | 55.0% | 53.6% | 48% |
|
| F-Score | na | 5 | na |
|
Evonik Industries AG did not pass any screens on 7/31/2026.
